OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

During an investigation into exposed OpenWebUI servers, the Cybernews research team identified a malicious campaign targeting vulnerable OpenWebUI servers with cryptocurrency miners and Info Stealers.

From a $5m admission ticket to a national scandal, Michael Palin and Terry Gilliam reveal how the Pythons survived the chaotic making of a masterpiece.

From Hugh Grant to Scarlett Johansson, these actors won a BAFTA for a lead role despite not even receiving an Oscar nomination.

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Merck & Co. is reorganizing its main pharmaceutical business in a bid to better prepare for a patent “cliff” threatening a large chunk of its future revenue. The big drugmaker on Monday said it’s ...

Python is a language that seems easy to do, especially for prototyping, but make sure not to make these common mistakes when coding.

WASHINGTON − A president who demands loyalty and has gotten used to winning at the Supreme Court didn’t hold back after the court on Feb. 20 struck down the sweeping tariffs that were the centerpiece ...

Rob Manfred is considering changes to MLB's schedule in upcoming seasons. Kirby Lee / Imagn Images Major League Baseball commissioner Rob Manfred said he is considering major shakeups to the league’s ...

After 14 failed votes and a 40-day-long shutdown, the Senate took its first step toward reopening the government on Sunday, with enough Democrats relenting on their healthcare demands to allow ...

Republicans are reeling after Democrats swept off-year races in several blue and purple states across the country on Tuesday, blaring a warning siren that their party may be in trouble ahead of the ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.